Full-Time

Head of Acute Portfolio Market Access

Reimbursement and Policy, Kidney Care

Posted on 11/21/2024

Baxter International

Baxter International

10,001+ employees

Provides essential medical products and services

Biotechnology
Healthcare

Compensation Overview

$168k - $231kAnnually

+ Bonus + Commission + Long-term Incentive

Expert

Highland Park, IL, USA

Category
Business Research
Strategy Development
Business Development
Business & Strategy
Requirements
  • Proven experience of global market access, HTA, reimbursement and evidence generation
  • Experience of at least 2 out of the following: Health Economics and Outcomes Research, Health Technology Assessment, Market Access, Real World Evidence (RWE)
  • Minimum of 15 years in field of Health Economics and Market Access including global, in country and regional roles
  • Experienced in collaborating and publishing with KOLs
  • Advanced degree (MS, MPH, PhD) in health economics, HTA and or Statistics
Responsibilities
  • Lead HEMAR Strategy for the ACUTE portfolio
  • Execute strategies in focus geographies in collaboration with regional teams
  • Responsibility for economic evidence generation for payers and providers including building capability across the commercial (evidence-based selling) and Medical Affairs organization
  • Strategic partner for New Product Development (R&D) value proposition: Non-clinical stakeholder dimension, value-based pricing, target product profile (TPP)

Baxter International provides a wide range of medical products and services essential for healthcare. The company operates in several areas, including critical care, hospital care, nutritional care, renal care, and surgical care. Its products are used in various settings, from emergency rooms to home healthcare, helping to meet the needs of patients and healthcare professionals globally. Baxter develops, manufactures, and distributes medical devices, pharmaceuticals, and biotechnology products, generating revenue through sales to healthcare providers and institutions. A key aspect that sets Baxter apart from competitors is its recent acquisition of Hillrom, which enhances its ability to offer comprehensive healthcare solutions. The company's goal is to improve care outcomes and increase access to healthcare through continuous innovation and a focus on patient needs.

Company Stage

Acquired

Total Funding

N/A

Headquarters

Deerfield, Illinois

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Baxter's investment in Medically Home positions it at the forefront of the growing trend towards hospital-level care at home, offering significant growth potential.
  • The partnership with Ayogo to enhance home dialysis solutions demonstrates Baxter's commitment to leveraging digital health innovations, potentially improving patient outcomes and satisfaction.
  • Baxter's broad portfolio across multiple healthcare segments provides stability and resilience against market fluctuations, offering employees a secure working environment.

What critics are saying

  • The integration of Hillrom and other acquisitions may present challenges in aligning corporate cultures and operational systems, potentially impacting efficiency.
  • Baxter's expansion into home healthcare could face regulatory hurdles and competition from established home care providers, affecting its market penetration.

What makes Baxter International unique

  • Baxter International's acquisition of Hillrom enhances its ability to provide comprehensive healthcare solutions, setting it apart from competitors who may not offer such integrated services.
  • The company's focus on a broad range of care segments, from critical to renal care, allows it to serve diverse healthcare needs, unlike competitors with narrower focuses.
  • Baxter's strategic investments, such as in Medically Home, highlight its commitment to innovative healthcare delivery models, distinguishing it from traditional healthcare providers.

Help us improve and share your feedback! Did you find this helpful?